|
Market Closed -
Other stock markets
|
Pre-market 07:07:36 | |||
| 48.03 EUR | +2.85% |
|
48.02 | -0.01% |
| 12-10 | MedTech Stocks Diverge Following Exane Report: 'A Split 2026' | DP |
| 12-04 | Britain's Frasers backs Hugo Boss' strategy and executive team | RE |
| Capitalization | 27.06B 31.51B 25.31B 23.64B 43.62B 2,833B 47.46B 293B 114B 1,343B 118B 116B 4,928B | P/E ratio 2025 * |
17.6x | P/E ratio 2026 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 38.48B 44.82B 35.99B 33.62B 62.04B 4,029B 67.5B 417B 163B 1,910B 168B 165B 7,008B | EV / Sales 2025 * |
1.71x | EV / Sales 2026 * | 1.59x |
| Free-Float |
73.04% | Yield 2025 * |
2.28% | Yield 2026 * | 2.45% |
More valuation ratios
* Estimated data
More news
Last Transcript: Fresenius SE & Co. KGaA
More recommendations
More press releases
More news
| 1 day | -0.01% | ||
| 1 week | +1.35% | ||
| Current month | +1.48% | ||
| 1 month | +0.25% | ||
| 3 months | +1.63% | ||
| 6 months | +9.21% | ||
| Current year | +43.20% |
| 1 week | 46.79 | 48.48 | |
| 1 month | 46.06 | 50.1 | |
| Current year | 31.6 | 50.74 | |
| 1 year | 31.6 | 50.74 | |
| 3 years | 23.29 | 50.74 | |
| 5 years | 19.69 | 50.74 | |
| 10 years | 19.69 | 80.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 57 | 30/09/2022 |
Sara Hennicken
DFI | Director of Finance/CFO | 45 | 31/08/2022 |
Michael Moser
CMP | Compliance Officer | 49 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 71 | 19/05/2015 |
| Director/Board Member | 65 | 12/05/2016 | |
| Director/Board Member | 51 | 31/12/2007 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
| 1.05% | 962 M€ | -.--% | - | |
| 1.01% | 0 M€ | -.--% | - | |
| 0.92% | 1 M€ | +50.93% | - | |
| 0.92% | 1 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.85% | +1.35% | +41.72% | +80.09% | 31.51B | ||
| -4.05% | -3.71% | +47.96% | +97.29% | 107B | ||
| +0.93% | +5.29% | +43.19% | -22.31% | 100B | ||
| +0.54% | +5.29% | -14.02% | +18.17% | 24.14B | ||
| +1.52% | -1.42% | +11.70% | +12.17% | 21.72B | ||
| -0.06% | -1.70% | +13.28% | +20.60% | 19.97B | ||
| -0.14% | -3.69% | +59.57% | +67.06% | 17.76B | ||
| -2.24% | -6.56% | +41.96% | +351.36% | 17.35B | ||
| -1.11% | -3.17% | +16.25% | +75.02% | 13.92B | ||
| +2.26% | -1.12% | -12.27% | +31.48% | 13.26B | ||
| Average | -0.48% | -0.98% | +24.94% | +73.09% | 36.68B | |
| Weighted average by Cap. | -0.97% | -0.00% | +34.91% | +56.04% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 22.55B 26.26B 21.09B 19.7B 36.35B 2,361B 39.55B 245B 95.29B 1,119B 98.56B 96.47B 4,107B | 23.74B 27.65B 22.2B 20.74B 38.27B 2,485B 41.64B 257B 100B 1,178B 104B 102B 4,323B |
| Net income | 1.55B 1.8B 1.45B 1.35B 2.5B 162B 2.72B 16.79B 6.54B 76.82B 6.77B 6.62B 282B | 1.94B 2.26B 1.81B 1.7B 3.13B 203B 3.4B 21.04B 8.2B 96.29B 8.48B 8.3B 353B |
| Net Debt | 11.43B 13.31B 10.69B 9.98B 18.42B 1,196B 20.04B 124B 48.28B 567B 49.94B 48.88B 2,081B | 10.61B 12.36B 9.92B 9.27B 17.11B 1,111B 18.61B 115B 44.84B 527B 46.38B 45.4B 1,932B |
More financial data
* Estimated data
Employees
177,356
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 48.04 € | +2.30% | 786,413 |
| 09/12/25 | 46.96 € | -1.45% | 424,309 |
| 08/12/25 | 47.65 € | +0.21% | 507,785 |
| 05/12/25 | 47.55 € | -0.65% | 478,199 |
| 04/12/25 | 47.86 € | +0.99% | 678,710 |
Delayed Quote Xetra, December 10, 2025 at 05:11 pm
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
14
Last Close Price
48.04EUR
Average target price
54.26EUR
Spread / Average Target
+12.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FRE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















